Clinical trial
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
NCT04649229 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
- Lead sponsor
- Yale University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 27, 2021
- Completion date
- May 22, 2025
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.